Massachusetts Financial Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-270,130
| Closed | -$53.2M | – | 852 |
|
|
2022
Q3 | $53.2M | Sell |
270,130
-590,305
| -69% | -$116M | 0.02% | 430 |
|
|
2022
Q2 | $184M | Sell |
860,435
-281,787
| -25% | -$60.3M | 0.06% | 259 |
|
|
2022
Q1 | $324M | Sell |
1,142,222
-149,893
| -12% | -$42.6M | 0.1% | 191 |
|
|
2021
Q4 | $487M | Sell |
1,292,115
-65,131
| -5% | -$24.5M | 0.13% | 160 |
|
|
2021
Q3 | $560M | Sell |
1,357,246
-81,163
| -6% | -$33.5M | 0.16% | 145 |
|
|
2021
Q2 | $532M | Buy |
1,438,409
+59,970
| +4% | +$22.2M | 0.16% | 152 |
|
|
2021
Q1 | $400M | Buy |
1,378,439
+6,689
| +0.5% | +$1.94M | 0.12% | 167 |
|
|
2020
Q4 | $343M | Buy |
1,371,750
+103,869
| +8% | +$26M | 0.11% | 179 |
|
|
2020
Q3 | $287M | Buy |
1,267,881
+409,339
| +48% | +$92.7M | 0.1% | 186 |
|
|
2020
Q2 | $150M | Buy |
858,542
+269,611
| +46% | +$47M | 0.06% | 253 |
|
|
2020
Q1 | $74.3M | Buy |
588,931
+352,637
| +149% | +$44.5M | 0.04% | 314 |
|
|
2019
Q4 | $36.1M | Buy |
236,294
+7,247
| +3% | +$1.11M | 0.01% | 455 |
|
|
2019
Q3 | $30.3M | Buy |
229,047
+54,841
| +31% | +$7.26M | 0.01% | 472 |
|
|
2019
Q2 | $24.7M | Buy |
174,206
+16,211
| +10% | +$2.3M | 0.01% | 510 |
|
|
2019
Q1 | $22.9M | Sell |
157,995
-25,959
| -14% | -$3.77M | 0.01% | 511 |
|
|
2018
Q4 | $20.8M | Sell |
183,954
-64,957
| -26% | -$7.35M | 0.01% | 497 |
|
|
2018
Q3 | $33.5M | Buy |
248,911
+46,195
| +23% | +$6.21M | 0.01% | 457 |
|
|
2018
Q2 | $22.8M | Buy |
202,716
+79,619
| +65% | +$8.94M | 0.01% | 494 |
|
|
2018
Q1 | $13.1M | Buy |
+123,097
| New | +$13.1M | 0.01% | 576 |
|